Pilot feasibility study of weekly Taxol [paclitaxel] and definitive radiation in androgen ablated locally advanced prostate cancer

Trial Profile

Pilot feasibility study of weekly Taxol [paclitaxel] and definitive radiation in androgen ablated locally advanced prostate cancer

Completed
Phase of Trial: Phase I/II

Latest Information Update: 04 Oct 2016

At a glance

  • Drugs Paclitaxel (Primary)
  • Indications Prostate cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Nov 2007 Results presented at the 49th Annual Meeting of the American Society for Therapeutic Radiology and Oncology.
    • 14 Feb 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top